Healthcare

Genetic Testing Market Growth Outlook, Trends, Scope, Competitor Analysis and Forecast 2021 to 2030

Share This Article

Genetic Testing Market size was valued at USD 8 billion in 2021 and is expected to reach over USD 15.8 billion by 2030, growing at a CAGR of 7.6% during the forecast period 2021 to 2030.

Growth Factors – The rising prevalence of chronic diseases and technological advancements resulted in the development of efficient and innovative genetic testing kits. The rising awareness regarding the benefits of genetic testing among the global population is boosting the adoption of the genetic testing. Furthermore, the growing geriatric population across the globe is expected to drive the demand for the genetic testing as old age people are prone to the chronic diseases.

Get the sample pages of report@ https://www.precedenceresearch.com/sample/1389

Report Highlights

  • North America dominated the market in 2020. This is due to the increased awareness regarding the benefits of genetic testing, increased consumer expenditure on healthcare, growing geriatric population, and increased prevalence of chronic diseases in the region.
  • Asia Pacific is expected to register a significant growth rate during the forecast period. This is due to the rising government initiatives to spread the awareness regarding the genetic testing.
  • Based on the test type, the prenatal & newborn testing segment is expected to be the fastest-growing segment during the forecast period.
  • Based on the disease, the cancer segment dominated the market in 2020. This is simply attributed to the rising prevalence of various cancer diseases among the population such as breast cancer, lungs cancer, bowel cancer, and womb cancer.

Ask here for customization study@ https://www.precedenceresearch.com/customization/1389

OBJECTIVES OF THE STUDY

  • To analyze and forecast the Genetic Testing market, in terms of value and volume
  • To provide information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To define, segment, and project the size of the global Genetic Testing market on the product type, end-use and other segments
  • To project the size of the market, with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), the Middle East & Africa, and South America, with their key countries
  • To strategically analyze micromarkets with respect to individual growth trends, growth prospects, and their contribution to the total market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To strategically profile key players and comprehensively analyze their core competencies
  • To track and analyze research & development (R&D) and competitive developments such as joint ventures, mergers & acquisitions, and new product developments in the Genetic Testing market

Research Methodology

  • Market estimate for 2021
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Major Players Covered in this Report

The updated market research report on Genetic Testing market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers
The major players operating in the genetic testing market are Genentech Inc., Sorenson Genomics, LLC, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, Celera Genomics, Genomic Health, HTG Molecular Diagnostics, PacBio.

Segments Covered in the Report

By Test Type

  • Carrier Testing
  • Predictive Testing
  • Diagnostic Testing
  • Prenatal & Newborn Testing
  • Nutrigenomics
  • Pharmacogenomics
  • Others

By Disease

  • Cancer
  • Alzheimer’s
  • Thalassemia
  • Cystic Fibrosis
  • Huntington’s Disease
  • Duchenne Muscular Dystrophy
  • Other Diseases

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genetic Testing Market 

5.1. COVID-19 Landscape: Genetic Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genetic Testing Market, By Test

8.1. Genetic Testing Market, by Test Type, 2021-2030

8.1.1. Carrier Testing

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Predictive Testing

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Diagnostic Testing

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Prenatal & Newborn Testing

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Nutrigenomics

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Pharmacogenomics

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Genetic Testing Market, By Disease

9.1. Genetic Testing Market, by Disease, 2021-2030

9.1.1. Cancer

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Alzheimer’s

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Thalassemia

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Cystic Fibrosis

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Huntington’s Disease

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Duchenne Muscular Dystrophy

9.1.6.1. Market Revenue and Forecast (2019-2030)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Genetic Testing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Test (2019-2030)

10.1.2. Market Revenue and Forecast, by Disease (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Disease (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Test (2019-2030)

10.2.2. Market Revenue and Forecast, by Disease (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Disease (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Test (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Disease (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Test (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Disease (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Disease (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Test (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Disease (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Test (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Disease (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.4.2. Market Revenue and Forecast, by Disease (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Disease (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Test (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Disease (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Test (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Disease (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Test (2019-2030)

10.5.2. Market Revenue and Forecast, by Disease (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Test (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Disease (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Test (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Disease (2019-2030)

Chapter 11. Company Profiles

11.1. Genentech Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Sorenson Genomics, LLC

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Abbott Molecular

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Bayer Diagnostics

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Biocartis

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. BioHelix

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Celera Genomics

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Genomic Health

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. HTG Molecular Diagnostics

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. PacBio

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1389

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Show More

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

Related Articles

Back to top button